As evidence grew this spring that the drug remdesivir was helping COVID-19 patients, some Wall Street investors bet on analysts’ estimates that its maker, Gilead Sciences Inc., could charge up to $10,000 for the treatment. Then a small but increasingly …
The largest lobbying group for health insurers has asked U.S. lawmakers weighing the fate of Obamacare to push back the due date for 2018 individual insurance submissions to regulators in hopes of obtaining greater clarity on the program’s future later …
The latest study of medicine prices finds U.S. insurers’ spending on expensive prescription drugs nearly quadrupled from 2003 through 2014, when the number of such prescriptions filled tripled. Spending on expensive “specialty” drugs by commercial insurance plans jumped from 11 …
Some health insurers are hoping to ease headaches that can flare when customers try to confirm whether a doctor is covered in a plan’s network of providers. The trade association America’s Health Insurance Plans will soon start testing a more …
There are 70,000 ways to get sick, hurt or mortally injured, and the U.S. is making them official. Last Thursday, U.S. hospitals, doctors and other care providers had to start using internationally developed standards called ICD-10 codes to bill government …
The battle over soaring U.S. drug prices is heading for the states. With the price of some treatments topping $100,000, patient groups are pushing for state laws to make sure insurers cover most of the costs. Their campaign is backed …
The Supreme Court briefs are in, and we can now say that big business backs Obamacare. The justices will hear oral arguments on March 4 in the latest case challenging the Affordable Care Act (ACA). At issue is the act’s …
The leading U.S. health insurance trade group on Tuesday hit out at the extremely high cost of new specialty medicines, accusing drugmakers of taking advantage of the insurance system by pricing products at unsustainable levels. The latest salvo in the …
The Obama administration on Friday finalized new consumer safeguards for health insurance that impose tighter restrictions on what insurers can charge older customers, despite industry warnings that the young may be forced to pay more as a result. The Department …
